The purpose of this legislation, known as the "New Era of Preventing End-Stage Kidney Disease Act," is to enhance efforts to prevent and manage rare kidney diseases, particularly focusing on end-stage kidney disease. It aims to improve research, increase public awareness, and provide better training for healthcare providers to address these conditions effectively. Key provisions of the legislation include the establishment of Centers of Excellence for research on rare kidney diseases, which will receive funding to conduct studies on the causes, symptoms, and treatments of these diseases.